News
Having significant capital in the bank when investing in equities is helpful, but is by no means necessary. If you're patient ...
Pfizer Inc. stock hits a 12-year low due to M&A missteps and high debt. Click here to find out why I rate PFE stock a Hold.
Good day, and welcome to the Bristol Myers Squibb First Quarter 2025 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation, there ...
Taho Pharmaceuticals’s apixaban-based oral dissolving strips were discovered to be a bioequivalent of Pfizer and Bristol-Myers Squibb’s (BMS) Eliquis in a Phase II trial. The randomised open ...
8d
24/7 Wall St. on MSNOne Sector Paying Big Dividends Is Off to the Best Start in 25 Years Despite TariffsFour healthcare dividend stocks with significant upside potential and safe dividends look like outstanding investing ideas ...
The Trump administration aims to change the Medicare Drug Price Negotiation Program in a way that would delay when certain ...
Pharmaceutical and biotechnology company Pfizer marks 70 years of dedication to its mission of advancing patient health in ...
A judge issued her order after Trump officials continually refused to retrieve Abrego Garcia, saying they defied a ...
Hosted on MSN15d
Regeneron reports positive results for two anti-coagulant drugsPfizer (PFE) and Bristol-Myers Squibb (BMY) market apixaban under the brand name Eliquis, while Sanofi (SNY) sells enoxaparin under the name Lovenox. The drugs are also available generically.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results